Rheumavax still needs FDA approval. It's still in the clinical trial phase. Doctors hope to find a way for it to work quicker, simpler, and cheaper. It takes a long time to remove, treat, and replace your dendrite cells.
Still, a 2015 study shows promise: The folks who got the shot showed no signs of inflammation or rheumatoid arthritis (RA) flare-ups a month later.
Once they’ve figured out a quicker prep process and how to get costs down, doctors hope they can make similar kinds of therapies for other autoimmune conditions like type 1 diabetes.